Bedford, MA – According to filings with the U.S. Securities and Exchange Commission, Instylla is raising $25,425,007.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Amar Sawhney played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Instylla

Instylla’s focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis. Instylla is the newest company formed by Incept LLC, an accelerator for the promotion and advancement of technology innovation and entrepreneurship, with its focus primarily in the life-sciences space. Incept has started 13 successful companies in the last 17 years.

To learn more about Instylla, visit http://www.instylla.com/

Contact:
Amar Sawhney, Chief Executive Officer
781-790-4860
https://www.linkedin.com/in/amar-sawhney-a4b143/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved